---
title: "STIRLING ANGLIAN PHARMACEUTICALS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/6b2e8ff7-e5bd-5bf3-9d20-f8e4e0bf89d1
json: https://whiteintel.dev/api/public/dossier/6b2e8ff7-e5bd-5bf3-9d20-f8e4e0bf89d1
identifier: oo:GB-COH-SC453258
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# STIRLING ANGLIAN PHARMACEUTICALS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-SC453258`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/6b2e8ff7-e5bd-5bf3-9d20-f8e4e0bf89d1  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/6b2e8ff7-e5bd-5bf3-9d20-f8e4e0bf89d1  

## Ownership & control

### Owners / controllers

- **Mr Sean Ambrose Perrie** (beneficial owner) — 75% — https://whiteintel.dev/entity/08d28297-3121-55ca-b1da-7b07055a775d
- **KELSO INTERNATIONAL LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/45e185bd-814d-53f1-abab-447c03031155
- **Mr Sean Ambrose Perrie** (beneficial owner) — 62.5% — https://whiteintel.dev/entity/88f44a00-534c-4670-bbcd-c4fd760a9942
- **KELSO INTERNATIONAL LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/45e185bd-814d-53f1-abab-447c03031155

### UBO chain (walk to the ultimate owner)

A **17-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `SC453258`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2013-06-26
- **Registered office:** Hillington Park Innovation Centre Ainslie Road, Hillington Park, Glasgow, G52 4RU
- **SIC:** 86900

### Officers

- INKER, Mark Charles — director · British · appointed 2023-02-20
- KING, Alan Fernie — director · British · appointed 2025-07-29
- MCLEAN, Andrew Firth — director · British · appointed 2021-12-21
- STRATFORD, Harry Thomas, Dr — director · British · appointed 2021-12-21
- ALSOP, Matthew Robert — director · British · appointed 2013-10-09 · resigned 2016-10-13
- COOK, Mark — director · British · appointed 2013-10-09 · resigned 2021-12-21
- FARQUHARSON, Carol Ann — director · British · appointed 2014-01-31 · resigned 2017-01-04
- MCMENEMY, Philip, Dr — director · British · appointed 2013-10-09 · resigned 2016-09-05
- NEUMAIER, Gerhard Wilhelm — director · German · appointed 2014-07-15 · resigned 2017-07-14
- PERRIE, Sean Ambrose — director · British · appointed 2013-06-26 · resigned 2021-12-21
- SCULLION, Stephen Peter — director · British · appointed 2015-02-01 · resigned 2016-10-14
- THORBURN, Alastair — director · British · appointed 2013-10-09 · resigned 2014-12-31
- WATSON, Allan Mark — director · British · appointed 2021-12-21 · resigned 2025-07-28
- WESTAWAY, Karen Mary — director · British · appointed 2013-10-09 · resigned 2015-04-01

### Beneficial owners (Persons with Significant Control)

- [Kelso International Limited](https://whiteintel.dev/entity/45e185bd-814d-53f1-abab-447c03031155) — 75–100% shares · corporate PSC · England — since 2021-12-21
- Mr Sean Ambrose Perrie — 50–75% shares · individual PSC — ceased 2021-12-21

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/SC453258
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/SC453258

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **STIRLING ANGLIAN PHARMACEUTICALS LIMITED** — https://whiteintel.dev/entity/6b2e8ff7-e5bd-5bf3-9d20-f8e4e0bf89d1 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **STIRLING ANGLIAN PHARMACEUTICALS LIMITED**. Human view: https://whiteintel.dev/entity/6b2e8ff7-e5bd-5bf3-9d20-f8e4e0bf89d1 · Structured JSON: https://whiteintel.dev/api/public/dossier/6b2e8ff7-e5bd-5bf3-9d20-f8e4e0bf89d1._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._